✦ LIBER ✦

O02 Developing therapies for human mitochondrial diseases

✍ Scribed by M. Murphy

Book ID: 117670303
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 73 KB
Volume: 21
Category: Article
ISSN: 0960-8966
DOI: 10.1016/s0960-8966(11)70003-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Why are there no proven therapies for ge

Why are there no proven therapies for genetic mitochondrial diseases?

✍ Peter W. Stacpoole 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Challenges in Developing Therapies for R

Challenges in Developing Therapies for Rare Diseases Including Pachyonychia Congenita

✍ Kaspar, Roger L. 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 177 KB

O4-02-08: Mitochondrial autophagocytosis

O4-02-08: Mitochondrial autophagocytosis in Alzheimer disease

✍ Paula I. Moreira; Sandra L. Siedlak; Maria S. Santos; Catarina R. Oliveira; Hisa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Developing Preventive Therapies for Chro

Developing Preventive Therapies for Chronic Diseases: Lessons Learned from Alzheimer's Disease

✍ Dennis J. Selkoe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Gene therapy of mitochondrial diseases u

Gene therapy of mitochondrial diseases using human cytoplasts

✍ Kagawa, Y; Hayashi, J-I 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 775 KB

Mitochondrial therapies for Parkinson's

Mitochondrial therapies for Parkinson's disease

✍ Bobby Thomas; M. Flint Beal 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract Parkinson's disease (PD) is marked by widespread neurodegeneration in the brain in addition to a selective yet prominent and progressive loss of nigrostriatal dopaminergic neurons. Of the multiple theories suggested in the pathogenesis of PD, mitochondrial dysfunction takes a center sta